Earnings Call · Q2 FY2021·2021-08-03

Q2 21EPS +9.09%·Rev n/aQ1 21EPS -56.96%·Rev n/aQ4 20EPS +9.80%·Rev n/aQ3 20EPS -31.82%·Rev n/a⚠ consensus missing

Theravance Biopharma, Inc. TBPH

Gail Cohen — Head of Investor Relations

Rick Winningham — Chief Executive Officer

Rick Graham — Chief Medical Officer

Frank Pasqualone — Head of Commercial or Commercial Leader

Andrew Hindman — Chief Financial Officer

−4.6%1d on move date−4.1% vs SPY3d−4.6%5d−0.8%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TBPH calls or request research access.

More TBPH calls Browse calls Request research access